Enhancement of (211)At Uptake via the Sodium Iodide Symporter by the Addition of Ascorbic Acid in Targeted α-Therapy of Thyroid Cancer

(211)At is an α-emitter that has similar chemical properties to iodine and is used in targeted α-therapy. In the present study, we added ascorbic acid (AA) to (211)At solution to increase the radiochemical purity of astatide and evaluated its efficacy against differentiated thyroid cancer, which is...

Descripción completa

Detalles Bibliográficos
Autores principales: Watabe, Tadashi, Kaneda-Nakashima, Kazuko, Liu, Yuwei, Shirakami, Yoshifumi, Ooe, Kazuhiro, Toyoshima, Atsushi, Shimosegawa, Eku, Fukuda, Mitsuhiro, Shinohara, Atsushi, Hatazawa, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society of Nuclear Medicine 2019
Materias:
Theranostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6735285/
https://www.ncbi.nlm.nih.gov/pubmed/30796173
http://dx.doi.org/10.2967/jnumed.118.222638

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6735285/
https://www.ncbi.nlm.nih.gov/pubmed/30796173
http://dx.doi.org/10.2967/jnumed.118.222638

Ejemplares similares